Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, childr...

Por Garcia-Sicilia, José, Arístegui, Javier, Omeñaca, Félix, Carmona, Alfonso, Tejedor, Juan C, Merino, José M, García-Corbeira, Pilar, Walravens, Karl, Bambure, Vinod, Moris, Philippe, Caplanusi, Adrian, Gillard, Paul, Dieussaert, Ilse
Publicado no Hum Vaccin Immunother (2015)

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: result...

Por Launay, Odile, Duval, Xavier, Fitoussi, Serge, Jilg, Wolfgang, Kerdpanich, Angkool, Montellano, May, Schwarz, Tino F, Watanveerade, Veerachai, Wenzel, Jürgen J, Zalcman, Gerard, Bambure, Vinod, Li, Ping, Caplanusi, Adrian, Madan, Anuradha, Gillard, Paul, Vaughn, David W
Publicado em 2013